BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15208305)

  • 1. Activation of Ras-Ral pathway attenuates p53-independent DNA damage G2 checkpoint.
    Agapova LS; Volodina JL; Chumakov PM; Kopnin BP
    J Biol Chem; 2004 Aug; 279(35):36382-9. PubMed ID: 15208305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
    Minemoto Y; Uchida S; Ohtsubo M; Shimura M; Sasagawa T; Hirata M; Nakagama H; Ishizaka Y; Yamashita K
    Arch Biochem Biophys; 2003 Apr; 412(1):13-9. PubMed ID: 12646262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle attenuation by p120E4F is accompanied by increased mitotic dysfunction.
    Rooney RJ
    Cell Growth Differ; 2001 Oct; 12(10):505-16. PubMed ID: 11682462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner.
    Santana C; Ortega E; García-Carrancá A
    Mutat Res; 2002 Oct; 508(1-2):49-58. PubMed ID: 12379461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
    Poon RY; Chau MS; Yamashita K; Hunter T
    Cancer Res; 1997 Nov; 57(22):5168-78. PubMed ID: 9371520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
    Minemoto Y; Gannon J; Masutani M; Nakagama H; Sasagawa T; Inoue M; Masamune Y; Yamashita K
    Exp Cell Res; 2001 Jan; 262(1):37-48. PubMed ID: 11120603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
    Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
    J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the G2/M transition by p53.
    Taylor WR; Stark GR
    Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis.
    Leach SD; Scatena CD; Keefer CJ; Goodman HA; Song SY; Yang L; Pietenpol JA
    Cancer Res; 1998 Aug; 58(15):3231-6. PubMed ID: 9699647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53.
    Athar M; Kim AL; Ahmad N; Mukhtar H; Gautier J; Bickers DR
    Biochem Biophys Res Commun; 2000 Oct; 277(1):107-11. PubMed ID: 11027648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.
    Murphy GA; Graham SM; Morita S; Reks SE; Rogers-Graham K; Vojtek A; Kelley GG; Der CJ
    J Biol Chem; 2002 Mar; 277(12):9966-75. PubMed ID: 11788587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
    McVean M; Weinberg WC; Pelling JC
    Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Ras signaling specificity by protein kinase C.
    Rusanescu G; Gotoh T; Tian X; Feig LA
    Mol Cell Biol; 2001 Apr; 21(8):2650-8. PubMed ID: 11283245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase D stimulation by receptor tyrosine kinases mediated by protein kinase C and a Ras/Ral signaling cascade.
    Voss M; Weernink PA; Haupenthal S; Möller U; Cool RH; Bauer B; Camonis JH; Jakobs KH; Schmidt M
    J Biol Chem; 1999 Dec; 274(49):34691-8. PubMed ID: 10574935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells.
    Wilson DW; Lamé MW; Dunston SK; Segall HJ
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):69-80. PubMed ID: 10896848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.
    Deming PB; Flores KG; Downes CS; Paules RS; Kaufmann WK
    J Biol Chem; 2002 Sep; 277(39):36832-8. PubMed ID: 12147700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.
    Jin S; Tong T; Fan W; Fan F; Antinore MJ; Zhu X; Mazzacurati L; Li X; Petrik KL; Rajasekaran B; Wu M; Zhan Q
    Oncogene; 2002 Dec; 21(57):8696-704. PubMed ID: 12483522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage.
    Jin P; Hardy S; Morgan DO
    J Cell Biol; 1998 May; 141(4):875-85. PubMed ID: 9585407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of RalGDS can be achieved independently of its Ras binding domain. Implications of an activation mechanism in Ras effector specificity and signal distribution.
    Linnemann T; Kiel C; Herter P; Herrmann C
    J Biol Chem; 2002 Mar; 277(10):7831-7. PubMed ID: 11748241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
    Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
    Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.